DALLAS, June 27, 2024 /PRNewswire/ — Jacobs (NYSE:J) was selected by FUJIFILM Diosynth Biotechnologies to support delivery of $1.2 billion expansion of an end-to-end, large-scale cell culture contract manufacturing site in Holly Springs, North Carolina. Jacobs was originally selected to…